As of 2025-07-05, the Intrinsic Value of CareRx Corp (CRRX.TO) is 8.44 CAD. This CRRX.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 2.88 CAD, the upside of CareRx Corp is 192.90%.
The range of the Intrinsic Value is 4.65 - 28.25 CAD
Based on its market price of 2.88 CAD and our intrinsic valuation, CareRx Corp (CRRX.TO) is undervalued by 192.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 4.65 - 28.25 | 8.44 | 192.9% |
| DCF (Growth 10y) | 8.46 - 47.36 | 14.73 | 411.5% |
| DCF (EBITDA 5y) | 2.95 - 4.68 | 3.71 | 28.7% |
| DCF (EBITDA 10y) | 5.96 - 9.63 | 7.52 | 161.2% |
| Fair Value | -0.76 - -0.76 | -0.76 | -126.28% |
| P/E | (1.03) - 0.20 | (0.45) | -115.7% |
| EV/EBITDA | 0.92 - 3.98 | 2.54 | -11.8% |
| EPV | 13.32 - 21.43 | 17.37 | 503.3% |
| DDM - Stable | (1.04) - (13.91) | (7.47) | -359.4% |
| DDM - Multi | 5.54 - 57.77 | 10.11 | 250.9% |
| Market Cap (mil) | 180.69 |
| Beta | 0.24 |
| Outstanding shares (mil) | 62.74 |
| Enterprise Value (mil) | 252.01 |
| Market risk premium | 5.10% |
| Cost of Equity | 5.72% |
| Cost of Debt | 11.39% |
| WACC | 7.33% |